COVID-19 (Coronavirus Disease 2019) is a severe global pandemic infection induced by a new coronavirus also known as SARS Coronavirus (SARS-CoV). It is a dynamic infection that affects different people in different ways; thus, a delay in the precise detection and treatment leads to the spread of the infection leading to more deaths. Automatic intelligent diagnostic models are thus needed to help detect such severe diseases at an early stage, thereby saving lives. For this, researchers developed a machine learning (ML) methodology for screening and COVID-19 classification using SARS-CoV2 CT scan images along with in-depth analysis of various features that is fascinating due to their better performance than conventional CT scan image classification for COVID-19. In addition, CT scan image feature extraction was measured using in-depth analysis with global and local feature descriptors. Principal component analysis (PCA) was employed to determine the optimal subset for COVID-19 recognition and classification. We compared and checked the best-in-class ML strategies on SARS-CoV2 CT scan images. The accuracy of training data was 98.78% and the accuracy of test data was 93.96% for a proposed model tested on the SARS-CoV2 CT scan images dataset. The findings of the experiment indicate a major improvement in COVID-19 classification, which aids in better COVID-19 investigation and disease prevention.
17Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
20Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.
Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.
23Guidance for the management of adult patients with coronavirus disease 2019.
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.
Read more106Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease.
Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease.
11COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past
COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past
116De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
7The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
86Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
15Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
66Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
40CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2
CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2
34COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
23Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Read more13Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
3Plasma exchange and COVID 19
Plasma exchange and COVID 19
Copyright 2026 Cactus Communications. All rights reserved.
